Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 17 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

41%

7 trials in Phase 3/4

Results Transparency

0%

0 of 10 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(35.7%)
Phase 4
4(28.6%)
Phase 3
3(21.4%)
Phase 2
2(14.3%)
14Total
N/A(5)
Phase 4(4)
Phase 3(3)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (17)

Showing 17 of 17 trials
NCT06830668Phase 4Not Yet Recruiting

Same-Day Restart of B/F/TAF in HIV Patients After NNRTI Discontinuation

Role: lead

NCT01315054Not ApplicableCompleted

A Methadone Maintenance Treatment Outcome Study in Three Provinces in China

Role: collaborator

NCT02712801Phase 4Completed

Antiretroviral Regime for Viral Eradication in Newborns

Role: collaborator

NCT01125696Phase 2Completed

Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV

Role: collaborator

NCT03852849Not ApplicableUnknown

Rapid Build of HIV Related Protective Barriers

Role: lead

NCT02231281Phase 3Unknown

Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults

Role: collaborator

NCT01210924Completed

Chinese Network of Pediatric Antiretroviral Therapy

Role: lead

NCT03320239Not ApplicableUnknown

Using HIV Risk Assessment Tool to Promote HIV Testing Among Men Who Have Sex With Men

Role: lead

NCT01764282Not ApplicableCompleted

Promoting Antiretroviral Therapy Among Serodiscordant Couples to Reduce HIV Transmission

Role: lead

NCT01904877Completed

Multi-component HIV Intervention Packages for Chinese Men Who Have Sex With Men -Test, Link and Care (TLC)

Role: collaborator

NCT01340950Phase 4Completed

Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China

Role: collaborator

NCT01892228Not ApplicableUnknown

Pilot Study of Immediate HIV Treatment in Guangxi, China

Role: lead

NCT01705223Phase 2Completed

Safety and Immunogenicity Study of AIDS Vaccine (Combined Use of DNA Vaccine and Recombinant Vaccinia Virus Tiantan)

Role: lead

NCT01751555Phase 4Completed

Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection

Role: lead

NCT01459575Completed

Unboosted Atazanavir as Initial ART Therapy in China

Role: lead

NCT01108614Phase 3Unknown

Injecting Drug Use Community Intervention Trial

Role: lead

NCT01068015Phase 3Unknown

(Men Who Have Sex With Men) MSM Community Intervention Trial

Role: lead

All 17 trials loaded